Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Van Wagoner

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Journal of Cardiovascular Pharmacology|September 16, 2008
Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic targetDavid R Van Wagoner
Journal of Cardiovascular Electrophysiology|July 24, 2003
Molecular basis of atrial fibrillation: a dream or a reality?David R Van Wagoner
Pacing and Clinical Electrophysiology : PACE|August 14, 2003
Electrophysiological remodeling in human atrial fibrillationDavid R Van Wagoner
Seminars in Thoracic and Cardiovascular Surgery|April 4, 2007
Recent insights into the pathophysiology of atrial fibrillationDavid R Van Wagoner
Journal of Cardiovascular Pharmacology|September 4, 2015
Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An UpdateAlejandra Gutierrez, David R Van Wagoner
Circulation Journal : Official Journal of the Japanese Circulation Society|March 10, 2015
Role of inflammation in atrial fibrillation pathophysiology and managementMasahide Harada, David R Van Wagoner, Stanley Nattel
International Journal of Cardiology|September 3, 2013
Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodelingFadia Mayyas, Karem H Alzoubi, David R Van Wagoner
Chest|October 4, 2016
OSA and Cardiac Arrhythmogenesis: Mechanistic InsightsAnna M May, David R Van Wagoner, Reena Mehra
FEBS Letters|October 24, 2006
Localization of Kv1.5 channels in rat and canine myocyte sarcolemmaJodene Eldstrom, David R Van Wagoner, Edwin D Moore, et al.
Plos One|December 5, 2018
Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidismFadia Mayyas, Nesreen Saadeh, Kusai Al-Muqbel, et al.
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Journal of Cardiovascular Pharmacology|September 16, 2008
Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic targetDavid R Van Wagoner
Journal of Cardiovascular Electrophysiology|July 24, 2003
Molecular basis of atrial fibrillation: a dream or a reality?David R Van Wagoner
Pacing and Clinical Electrophysiology : PACE|August 14, 2003
Electrophysiological remodeling in human atrial fibrillationDavid R Van Wagoner
Seminars in Thoracic and Cardiovascular Surgery|April 4, 2007
Recent insights into the pathophysiology of atrial fibrillationDavid R Van Wagoner
Journal of Cardiovascular Pharmacology|September 4, 2015
Oxidant and Inflammatory Mechanisms and Targeted Therapy in Atrial Fibrillation: An UpdateAlejandra Gutierrez, David R Van Wagoner
Circulation Journal : Official Journal of the Japanese Circulation Society|March 10, 2015
Role of inflammation in atrial fibrillation pathophysiology and managementMasahide Harada, David R Van Wagoner, Stanley Nattel
International Journal of Cardiology|September 3, 2013
Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodelingFadia Mayyas, Karem H Alzoubi, David R Van Wagoner
Chest|October 4, 2016
OSA and Cardiac Arrhythmogenesis: Mechanistic InsightsAnna M May, David R Van Wagoner, Reena Mehra
FEBS Letters|October 24, 2006
Localization of Kv1.5 channels in rat and canine myocyte sarcolemmaJodene Eldstrom, David R Van Wagoner, Edwin D Moore, et al.
Plos One|December 5, 2018
Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidismFadia Mayyas, Nesreen Saadeh, Kusai Al-Muqbel, et al.
Pageof 11